Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Anticipated Size Of The Isosorbide Mononitrate Tablet Market Over The Five-Year Period 2025–2029?
The isosorbide mononitrate tablet market has experienced consistent expansion in recent years. It is anticipated to grow from $1.14 billion in 2024 to $1.2 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.9%. The historical expansion can be attributed to an aging population, a rising frequency of heart-related conditions, improved knowledge of heart health, the availability of generic medications, and various public health endeavors.
The isosorbide mononitrate tablet market is projected to experience robust expansion over the coming years, with its size expected to grow to $1.47 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 5.3%. This growth during the forecast period is attributable to several factors, including regulatory approvals and patent expirations, increasing adoption of generic drugs, a rise in lifestyle-related risk factors, government initiatives for cardiovascular disease management, improvements in diagnostic infrastructure, and various awareness campaigns. Major trends anticipated in the forecast period include advancements in extended-release formulations, technological innovations, the emergence of digital health platforms and e-commerce, the integration of digital health technologies, and the strategic combination of isosorbide mononitrate with other cardiovascular drugs.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24268&type=smp
What Are The Drivers Pushing New Developments In The Isosorbide Mononitrate Tablet Market?
An increasing incidence of cardiovascular diseases is anticipated to drive the expansion of the isosorbide mononitrate tablet market in the future. These conditions, often abbreviated as CVDs, encompass various ailments impacting the heart and circulatory system, such as coronary artery disease, heart failure, and high blood pressure. The surge in cardiovascular disease cases largely stems from poor dietary habits, frequently characterized by excessive saturated and trans fats, sodium, and sugars, contributing to issues like obesity, hypertension, and elevated cholesterol. Isosorbide mononitrate tablets effectively assist in treating cardiovascular diseases by promoting the relaxation and dilation of blood vessels, subsequently enhancing blood flow and decreasing the heart’s strain. This action helps to mitigate chest discomfort (angina), lower blood pressure, and boost oxygen supply to the cardiac muscle. For instance, in December 2023, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that doctor-certified deaths due to coronary heart disease (CHD) rose to 14,100 in 2021 and subsequently climbed to 14,900 in 2022. Consequently, the increasing occurrence of cardiovascular diseases is a key factor propelling the expansion of the isosorbide mononitrate tablet market.
What Are The Segment Types Shaping The Isosorbide Mononitrate Tablet Market?
The isosorbide mononitrate tabletmarket covered in this report is segmented –
1) By Dosage Form: Immediate-Release Tablets; Extended-Release Tablets
2) By Indication Type: Angina Pectoris; Heart Failure; Hypertension
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Immediate-Release Tablets: Low-Dose; Single Strength Tablets; Combination With Other Drugs
2) By Extended-Release Tablets: Moderate-Dose; High-Dose; Once-Daily Formulation; Twice-Daily Formulation
What Trends Are Expected To Drive The Isosorbide Mononitrate Tablet Market?
Leading companies in the isosorbide mononitrate tablet market are prioritizing the development of innovative products, particularly extended-release (ER) formulations. This approach aims to improve patient adherence, ensure prolonged therapeutic effects, and optimize treatment results for conditions such as angina pectoris. An extended-release formulation represents an advanced drug delivery system, facilitating the gradual release of medication over an extended duration, which in turn reduces dosing frequency and maintains consistent blood levels. For example, in February 2024, Zydus Lifesciences Limited, an India-based pharmaceutical manufacturing company, obtained approval from the United States Food and Drug Administration (USFDA) to produce and commercialize isosorbide mononitrate extended-release tablets USP in strengths of 30 mg, 60 mg, and 120 mg. These tablets are prescribed to prevent chest pain (angina) in patients suffering from coronary artery disease and are considered equivalent to the reference listed drug (RLD), imdur extended-release tablets.
Who Are The Primary Competitors In The Global Isosorbide Mononitrate Tablet Market?
Major companies operating in the isosorbide mononitrate tablet market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, Abbott Laboratories Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Recipeharm, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lotus Pharmaceuticals, Healthy Inc., Qilu Pharmaceutical Co., Ltd, Lunan Pharmaceutical Group, Johnlee Pharmaceuticals Pvt. Ltd., Niksan Pharmaceutical, Shandong Keyuan Pharmaceutical, Prevego Healthcare & Research Private Limited.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/isosorbide-mononitrate-tablet-global-market-report
Which Global Regions Are Influencing The Competitive Landscape Of The Isosorbide Mononitrate Tablet Market?
North America was the largest region in the isosorbide mononitrate tablet market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the isosorbide mononitrate tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Isosorbide Mononitrate Tablet Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24268&type=smp
Browse Through More Reports Similar to the Global Isosorbide Mononitrate Tablet Market 2025, By The Business Research Company
Implantable Heart Pacemaker Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/implantable-heart-pacemaker-global-market-report
Heart Pump Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report
Wearable Heart Monitoring Devices Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model